CustomerInsights.AI, is pleased to announce capital investment from Cypress Growth Capital. Cypress’s non-dilutive growth capital will be invested in marketing, sales, and agentic AI expansion.
“CIAI is solving a critical need for Life Sciences commercial analytics organizations. We felt that outside funding would allow us to scale our go-to-market while continuing platform development,” said Abhay Jajoo, CIAI’s Co-founder and CEO. “We had several options when it came to choosing a growth capital partner. We selected Cypress because they understand our needs and challenges – they’re tech investors with successful founder and operator experience. And their non-dilutive, multi-tranche capital approach aligns with our growth plans without diluting founders and key employees.”
Also Read: MasterControl Unveils AI Chat to Simplify Life Sciences Compliance
The deep industry knowledge of CIAI’s team and their track record of growth were major factors in Cypress’s investment decision. “CIAI is a leader in a rapidly growing market,” said Vik Thapar, Managing Director of Cypress. “Abhay, Robin, and the CIAI team have translated their years of hands-on experience at the leading edge of Pharmaceutical Data into a powerful technology platform and specialized consulting solutions around the platform. The company is transforming how Life Sciences companies make key market decisions. We’re proud to partner with the CIAI team as they continue to grow.”
Source: PRNewswire
